ahn 086 has been researched along with pk 11195 in 3 studies
| Studies (ahn 086) | Trials (ahn 086) | Recent Studies (post-2010) (ahn 086) | Studies (pk 11195) | Trials (pk 11195) | Recent Studies (post-2010) (pk 11195) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 1,063 | 11 | 259 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basile, AS; Bravo, C; Chiang, PK; Hogue, BA; Moreno-Sánchez, R; Newman, AH | 1 |
| Lueddens, HW; Newman, AH; Rice, KC; Skolnick, P | 2 |
3 other study(ies) available for ahn 086 and pk 11195
| Article | Year |
|---|---|
Inhibition of substrate oxidation in mitochondria by the peripheral-type benzodiazepine receptor ligand AHN 086.
Topics: Adenosine Triphosphate; Animals; Benzodiazepinones; Binding Sites; Dose-Response Relationship, Drug; Isoquinolines; Kidney; Male; Mitochondria, Heart; Mitochondria, Liver; Oxidation-Reduction; Oxygen Consumption; Phosphorylation; Rats; Rats, Inbred Strains; Receptors, GABA-A | 1991 |
Novel irreversible ligands specific for "peripheral" type benzodiazepine receptors: (+/-)-, (+)-, and (-)-1-(2-chlorophenyl)-N-(1-methylpropyl)-N- (2-isothiocyanatoethyl)-3-isoquinolinecarboxamide and 1-(2-isothiocyanatoethyl)-7-chloro-1,3-dihydro-5-(4-ch
Topics: Animals; Benzodiazepinones; Brain; Hydrogen-Ion Concentration; Isoquinolines; Kidney; Male; Rats; Rats, Inbred Strains; Receptors, GABA-A; Stereoisomerism | 1987 |
Synthesis and biochemical characterization of two novel irreversible ligands specific for "peripheral" benzodiazepine receptors.
Topics: Animals; Benzodiazepinones; Brain; Chemical Phenomena; Chemistry; Isoquinolines; Kidney; Ligands; Male; Rats; Rats, Inbred Strains; Receptors, GABA-A | 1987 |